{"entity":{"id":"nct06031181","kind":"trial","name":"Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)","aka":[],"tldr":"A phase 3 trial in lung cancer, run by Fudan University, now recruiting.","summary":"Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019) is a phase 3, interventional study registered as NCT06031181 by Fudan University, with a registry enrolment figure of 390 participants, started 2023-03-31 and due to reach its primary completion in 2026-01-01. Interventions recorded: Sublobar Resection. Conditions listed: Lung Adenocarcinoma; Frozen Section; Sublobar Resection. Primary outcome: 5-year recurrence-free survival. Lung eligibility wording from the registry: \"Not receiving lung cancer surgery before;\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT06031181","url":"https://clinicaltrials.gov/study/NCT06031181"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["lung-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06031181","phase":"3","setting":"Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section: a Single-arm, Multi-center, Phase III Trial","sponsor":"Fudan University","enrolled":390,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06031181/","neighbours":{"cancer":[{"id":"lung-cancer","kind":"cancer","name":"Lung cancer (all types)","route":"/cancers/lung-cancer/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}